SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 101–200 of 1,001
Host and Viral Determinants of Mx2 Antiretroviral Activity
Busnadiego, I., Kane, M., Rihn, S. J., Preugschas, H. F., Hughes, J., Blanco-Melo, D., Strouvelle, V. P., Zang, T. M., Willett, B. J., Boutell, C., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00214-14 · Cited by 159
“SAMHD1 is likely to be similarly important in this regard (6, 7).”
Murray, A. J., Kwon, K. J., Färber, D. L., & Siliciano, R. F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600343 · Cited by 187
“Interestingly, SIV and HIV-2 encode a protein, Vpx, that promotes SAMHD1 degradation (68, 71).”
BackgroundSAMHD1‐dependent retroviral control and escape in mice
Rehwinkel, J., Maelfait, J., Bridgeman, A., Rigby, R. E., Hayward, B. E., Liberatore, R. A., Bieniasz, P. D., Towers, G. J., Moita, L. F., Crow, Y. J., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.163 · Cited by 173
“As such, HIV-1 partially escapes SAMHD1 restriction and in many instances is able to infect a small proportion of human myeloid cells (Duvall et al , 2007; Hrecka et al , 2011; Laguette et al , 2011; Lahouassa et al , 2012).”
InfluentialTetramerization of SAMHD1 Is Required for Biological Activity and Inhibition of HIV Infection
Yan, J., Kaur, S., DeLucia, M., Hao, C., Mehrens, J., Wang, C., Golczak, M., Palczewski, K., Gronenborn, A. M., Ahn, J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.443796 · Cited by 171
“This is underscored by previous findings that many AGS-associated mutations disrupt SAMHD1 catalytic activity and that inhibition of HIV infection is abolished by mutating the key histidine and aspartic acid residues in the HD domain catalytic center (13, 26).”
BackgroundResultInfluentialMARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins
Tada, T., Zhang, Y., Koyama, T., Tobiume, M., Tsunetsugu‐Yokota, Y., Yamaoka, S., Fujita, H., & Tokunaga, K. (2015) · Nature Medicine · doi:10.1038/nm.3956 · Cited by 158
Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac
Brandariz-Núñez, A., Valle‐Casuso, J. C., White, T. E., Laguette, N., Benkirane, M., Brojatsch, J., & Diaz‐Griffero, F. (2012) · Retrovirology · doi:10.1186/1742-4690-9-49 · Cited by 160
“N-terminally FLAG- and HA-tagged Vpxmac251, VpxROD, VpxRCM-NG [17] and HIV-2B have been previously described [31].”
BackgroundSelf-citationHost Factor SAMHD1 Restricts DNA Viruses in Non-Dividing Myeloid Cells
Hollenbaugh, J. A., Gee, P., Baker, J. L., Daly, M. B., Amie, S. M., Tate, J., Kasai, N., Kanemura, Y., Kim, D., Ward, B. M., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003481 · Cited by 169
“A series of recent studies highlighted SAMHD1, a cellular dNTP triphosphohydrolase, as an anti-lentiviral restriction factor predominantly found in myeloid cells [5,6,7,8,24,40,52].”
BackgroundDNA sensor cGAS-mediated immune recognition
Xia, P., Wang, S., Gao, P., Gao, G., & Fan, Z. (2016) · Protein & Cell · doi:10.1007/s13238-016-0320-3 · Cited by 165
“However, HIV-2 encodes Vpx that mediates SAMHD1 degradation through the CRL4-DCAF1 E3 ubiquitin ligase, resulting in HIV-2 replication in DCs and macrophages (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundRestrictions to HIV-1 replication in resting CD4+ T lymphocytes
Pan, X., Baldauf, H., Keppler, O. T., & Fackler, O. (2013) · Cell Research · doi:10.1038/cr.2013.74 · Cited by 181
HIV accessory proteins versus host restriction factors
Strebel, K. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.08.004 · Cited by 132
Restriction of diverse retroviruses by SAMHD1
Gramberg, T., Kahle, T., Bloch, N., Wittmann, S., Müllers, E., Daddacha, W., Hofmann, H., Kim, B., Lindemann, D., & Landau, N. R. (2013) · Retrovirology · doi:10.1186/1742-4690-10-26 · Cited by 137
“; licensee BioMed Cent Commons Attribution License (http://creativec reproduction in any medium, provided the or [1,2].”
The Vpx Lentiviral Accessory Protein Targets SAMHD1 for Degradation in the Nucleus
Hofmann, H., Logue, E. C., Bloch, N., Daddacha, W., Polsky, S. B., Schultz, M. L., Kim, B., & Landau, N. R. (2012) · Journal of Virology · doi:10.1128/jvi.01657-12 · Cited by 133
“The pretreatment of DC with Vpx-containing VLPs enhances vpx SIV and HIV-1 infections by as much as 100-fold (7, 14, 18, 26).”
BackgroundYurkovetskiy, L., Guney, M. H., Kim, K., Goh, S. L., McCauley, S., Dauphin, A., Diehl, W. E., & Luban, J. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0256-x · Cited by 143
Global virus outbreaks: Interferons as 1st responders
Wang, B. X., & Fish, E. N. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101300 · Cited by 148
Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1
White, T. E., Brandariz-Núñez, A., Valle‐Casuso, J. C., Amie, S. M., Nguyen, L. A., Kim, B., Brojatsch, J., & Diaz‐Griffero, F. (2012) · Virology · doi:10.1016/j.virol.2012.10.029 · Cited by 150
“Recent work identified SAMHD1 as the protein that blocks infection of SIVDVpx, HIV-2DVpx and HIV-1 before reverse transcription in macrophages and dendritic cells (Hrecka et al., 2011; Laguette et al., 2011).”
Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates
Milani, M., Annoni, A., Moalli, F., Liu, T., Cesana, D., Calabria, A., Bartolaccini, S., Biffi, M., Russo, F., Visigalli, I., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav7325 · Cited by 142
“Note that the high content of LV genome did not correspond to high transgene expression, consistent with the reported postentry restriction of LV transduction in human mature macrophages (22, 23).”
BackgroundA whole genome screen for HIV restriction factors
Liu, L., Oliveira, N. M. M., Cheney, K. M., Pade, C., Dreja, H. S., Bergin, A.-M. H., Borgdorff, V., Beach, D., Bishop, C. L., Dittmar, M. T., et al. (2011) · Retrovirology · doi:10.1186/1742-4690-8-94 · Cited by 164
Early cytoplasmic uncoating is associated with infectivity of HIV-1
Mamede, J. I., Cianci, G. C., Anderson, M. R., & Hope, T. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706245114 · Cited by 140
“Infection in MDMs might be expected to result in a slower capsid integrity loss since it has been reported that macrophages have relatively low dNTP concentrations (40, 48, 49) and delayed completion of reverse transcription (28).”
HIV-2/SIV viral protein X counteracts HUSH repressor complex
Chougui, G., Munir, S., Matkovic, R., Martin, M. M., Morel, M., Lahouassa, H., Leduc, M., Ramírez, B. C., Etienne, L., & Margottin-Goguet, F. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0179-6 · Cited by 152
Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness
Iyer, S. S., Bibollet‐Ruche, F., Sherrill-Mix, S. A., Learn, G. H., Plenderleith, L. J., Smith, A. G., Barbian, H. J., Russell, R. M., Gondim, M. V. P., Bahari, C. Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620144114 · Cited by 164
Nuclear import of the HIV-1 core precedes reverse transcription and uncoating
Selyutina, A., Persaud, M., Lee, K., KewalRamani, V., & Diaz-Griffero, F. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108201 · Cited by 144
“Next, we measured nuclear import of HIV-1 capsid in cells expressing the restriction factor SAMHD1, which is nuclear and inhibits RT (Hrecka et al., 2011; Laguette et al., 2011).”
Dendritic cells in progression and pathology of HIV infection
Manches, O., Frleta, D., & Bhardwaj, N. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.10.003 · Cited by 160
“Recently, SAMHD1 was identified as a major restriction factor in myeloid cells, blocking the postentry replication by arresting the virus at the minus strong strand stop DNA stage [35, 36].”
BackgroundGonçalves, A., Karayel, E., Rice, G., Bennett, K. L., Crow, Y. J., Superti‐Furga, G., & Bürckstümmer, T. (2012) · Human Mutation · doi:10.1002/humu.22087 · Cited by 154
“HIV-2, in contrast, is not restricted as it harbors the Vpx protein, which antagonizes SAMHD1 by recruiting an E3 ligase complex and triggering the proteasomal degradation of SAMHD1.”
BackgroundStructural basis of cellular dNTP regulation by SAMHD1
Ji, X., Tang, C., Zhao, Q., Wang, W., & Xiong, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412289111 · Cited by 146
“h SAMHD1dNi−dN2 i = Vmixture dNi ki2 app [5]”
BackgroundCyclophilin A protects HIV-1 from restriction by human TRIM5α
Kim, K., Dauphin, A., Komurlu, S., McCauley, S. M., Yurkovetskiy, L., Carbone, C., Diehl, W. E., Strambio-De-Castillia, C., Campbell, E. M., & Luban, J. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0592-5 · Cited by 133
Pauls, E., Ruiz, A., Badía, R., Permanyer, M., Gubern, A., Riveira‐Muñoz, E., Torres‐Torronteras, J., Álvarez, M., Mothe, B., Brander, C., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400873 · Cited by 153
Izquierdo‐Useros, N., Lorizate, M., McLaren, P. J., Telenti, A., Kräusslich, H., & Martínez‐Picado, J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004146 · Cited by 152
“In contrast to HIV-1, HIV-2 naturally infects DCs [20], and this function depends on counteraction of SAMHD1 by Vpx, a viral protein not present in HIV-1 [17,18].”
BackgroundTargeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
Herold, N., Rudd, S. G., Ljungblad, L. M., Sanjiv, K., Myrberg, I. H., Paulin, C. B. J., Heshmati, Y., Hagenkort, A., Kutzner, J., Page, B. D. G., et al. (2017) · Nature Medicine · doi:10.1038/nm.4265 · Cited by 145
Michels, K. R., Sheih, A., Hernández, S., Brandes, A., Parrilla, D., Irwin, B., Perez, A. M., Ting, H.-A., Nicolai, C. J., Gervascio, T., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006292 · Cited by 146
Structural basis of lentiviral subversion of a cellular protein degradation pathway
Schwefel, D., Groom, H. C. T., Boucherit, V. C., Christodoulou, E., Walker, P. A., Stoye, J. P., Bishop, K. N., & Taylor, I. A. (2014) · Nature · doi:10.1038/nature12815 · Cited by 127
Barriers for HIV Cure: The Latent Reservoir
Castro‐Gonzalez, S., Colomer-Lluch, M., & Serra-Moreno, R. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0118 · Cited by 158
Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity
Institute of Medicine and National Research Council (2011) · National Academies Press eBooks · doi:10.17226/13257 · Cited by 171
Nucleases Acting at Stalled Forks: How to Reboot the Replication Program with a Few Shortcuts
Pasero, P., & Vindigni, A. (2017) · Annual Review of Genetics · doi:10.1146/annurev-genet-120116-024745 · Cited by 136
Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications
Kohnken, R., Kodigepalli, K. M., & Wu, L. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0446-6 · Cited by 123
“SAMHD1 was identified in human myeloid cells as a novel HIV-1 restriction factor [5, 6].”
BackgroundAdoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Liu, Q., Li, J., Zheng, H., Yang, S., Hua, Y., Huang, N., Kleeff, J. H., Liao, Q., & Wu, W. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01735-9 · Cited by 144
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
Ananworanich, J., Dubé, K., & Chomont, N. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000122 · Cited by 128
Zhu, C., Gao, W., Zhao, K., Qin, X., Zhang, Y., Peng, X., Zhang, L., Dong, Y., Zhang, W., Li, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3722 · Cited by 141
SAMHD1 Restricts Herpes Simplex Virus 1 in Macrophages by Limiting DNA Replication
Kim, E. T., White, T. E., Brandariz-Núñez, A., Diaz-Griffero, F., & Weitzman, M. D. (2013) · Journal of Virology · doi:10.1128/jvi.02291-13 · Cited by 126
“It was identified through biochemical purification of the accessory factor Vpx encoded by certain lentiviruses (8, 9).”
BackgroundInfluentialSeamon, K. J., Sun, Z., Shlyakhtenko, L. S., Lyubchenko, Y. L., & Stivers, J. T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv633 · Cited by 126
“University of Nebraska Medical Center DigitalCommons@UNMC Journal Articles: Pharmaceutical Sciences Pharmaceutical Sciences Summer 7-27-2015 SAMHD1 is a single-stranded nucleic acid binding protein with no active site-associated nuclease activity.”
BackgroundDamage-associated molecular patterns (DAMPs) in diseases: implications for therapy
Lin, H., Xiong, W. G., Fu, L., Yi, J., & Yang, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00305-3 · Cited by 152
Tao, Y., Remillard, D., Vinogradova, E. V., Yokoyama, M., Banchenko, S., Schwefel, D., Melillo, B., Schreiber, S. L., Zhang, X., & Cravatt, B. F. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c08964 · Cited by 120
Constitutive resistance to viral infection in human CD141 + dendritic cells
Silvin, A., Yu, C. I., Lahaye, X., Imperatore, F., Brault, J.-B., Cardinaud, S., Becker, C., Kwan, W.-H., Conrad, C., Maurin, M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai8071 · Cited by 114
Souriant, S., Balboa, L., Dupont, M., Pingris, K., Kviatcovsky, D., Cougoule, C., Lastrucci, C., Bah, A., Gasser, R., Poincloux, R., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.091 · Cited by 133
SAMHD1 Inhibits LINE-1 Retrotransposition by Promoting Stress Granule Formation
Hu, S., Li, J., Xu, F., Mei, S., Le Duff, Y., Yin, L., Pang, X., Cen, S., Jin, Q., Liang, C., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005367 · Cited by 121
Calantone, N., Wu, F., Klase, Z. A., Deléage, C., Perkins, M. R., Matsuda, K., Thompson, E. A., Ortiz, A. M., Vinton, C. L., Ourmanov, I., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.014 · Cited by 119
“The activity of SAMHD1 is thought to involve its phosphorylation and is active in resting CD4 T cells andmyeloid cells, and its expression and activity are thought to limit infection of these cells by HIV/SIV (Baldauf et al., 2012; Laguette et al., 2011).”
InfluentialGene Loss and Adaptation to Hominids Underlie the Ancient Origin of HIV-1
Etienne, L., Hahn, B. H., Sharp, P. M., Matsen, F. A., IV, & Emerman, M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.002 · Cited by 126
“In contrast, neither HIV-1 nor SIVcpz, its immediate precursor, have the ability to degrade SAMHD1 because they do not encode a vpx gene, and their Vpr protein does not antagonize SAMHD1 (Laguette et al., 2011; Lim et al., 2012).”
Chen, S., Bonifati, S., Qin, Z., Gelais, C. S., Kodigepalli, K. M., Barrett, B. S., Kim, S. H., Antonucci, J. M., Ladner, K. J., Buzovetsky, O., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801213115 · Cited by 143
“S alpha motif and HD-domain–containing protein 1 (SAMHD1) was identified as a cellular restriction factor that inhibits HIV-1 infection in nondividing myeloid cells (1, 2).”
BackgroundKey Viral Adaptations Preceding the AIDS Pandemic
Sauter, D., & Kirchhoff, F. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2018.12.002 · Cited by 132
Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1
Maelfait, J., Bridgeman, A., Benlahrech, A., Cursi, C., & Rehwinkel, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.002 · Cited by 109
“An interesting comparison can be made with HIV-2, which overcomes SAMHD1-mediated restriction by encoding the antagonist Vpx (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundInfluentialMobilization of HIV Spread by Diaphanous 2 Dependent Filopodia in Infected Dendritic Cells
Aggarwal, A., Iemma, T. L., Shih, I., Newsome, T. P., McAllery, S., Cunningham, A. L., & Turville, S. G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002762 · Cited by 115
“SAMHD1 [17], the majority of data to date observe only limiting numbers of infected DCs being readily capable of rapidly seeding CD4 T cell infections [5,6,7,15].”
BackgroundIntrinsic Cellular Defenses against Human Immunodeficiency Viruses
Blanco-Melo, D., Venkatesh, S., & Bieniasz, P. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.013 · Cited by 132
“Simultaneous Vpr or Vpx binding to SAMHD1 leads to SAMHD1 ubiquitination and degradation by proteasomes (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundInfluentialHeterozygous colon cancer-associated mutations of SAMHD1 have functional significance
Rentoft, M., Lindell, K., Tran, P., Chabes, A. L., Buckland, R. J., Watt, D. L., Marjavaara, L., Nilsson, A. K., Melin, B. S., Trygg, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519128113 · Cited by 128
“Germ-line mutations in SAMHD1 have been associated with Aicardi–Goutieres syndrome, a congenital autoimmune disease (23), and more recently SAMHD1 was shown to be an HIV-1 restriction factor operating in nondividing blood cells (24, 25).”
BackgroundHegedus, A., Williamson, M. K., & Huthoff, H. (2014) · Retrovirology · doi:10.1186/s12977-014-0098-4 · Cited by 122
“For instance, the recent discovery of the restriction factor SAMHD1 has led to the insight that it hydrolyses deoxynucleotide triphosphates (dNTPs) to levels that are insufficient to support reverse transcription in monocytes, macrophages, dendritic and quiescent CD4+ T cells [17-21].”
BackgroundWang, X., Ao, Z., Chen, L., Kobinger, G., Peng, J., & Yao, X. (2012) · Journal of Virology · doi:10.1128/jvi.06594-11 · Cited by 121
“Several host proteins have been identified as intrinsic restriction factors because of their ability to inhibit HIV replication and/or dissemination (2, 31, 41, 52).”
BackgroundDendritic cell dysregulation during HIV ‐1 infection
Miller, E., & Bhardwaj, N. (2013) · Immunological Reviews · doi:10.1111/imr.12082 · Cited by 127
Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection
Menéndez‐Arias, L., & Álvarez, M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.12.001 · Cited by 118
Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions
Greenwood, A. D., Ishida, Y., O’Brien, S. P., Roca, A. L., & Eiden, M. V. (2017) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00044-17 · Cited by 120
“A more recent discovery is SAMHD1, which can inhibit cDNA synthesis of HIV-1 when viral protein X (Vpx) is inhibited (254).”
BackgroundHost and viral determinants for MxB restriction of HIV-1 infection
Matreyek, K. A., Wang, W., Serrao, E., Singh, P. K., Levin, H. L., & Engelman, A. (2014) · Retrovirology · doi:10.1186/s12977-014-0090-z · Cited by 103
“mRNA editing enzyme, catalytic polypeptide-like (APOBEC) 3G [1], tripartite motif (TRIM) 5α [2] and TrimCyp [3], SAM domain and HD domain-containing protein (SAMHD) 1 [4,5], and bone marrow stromal cell antigen (BST) 2/Tetherin [6,7].”
BackgroundAre T cells the only HIV-1 reservoir?
Kandathil, A. J., Sugawara, S., & Balagopal, A. (2016) · Retrovirology · doi:10.1186/s12977-016-0323-4 · Cited by 103
“Instead, they encode for vpx, which may be a critical difference: vpx degrades SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 (SAMHD1), a key retroviral restriction factor in macrophages and DCs [125, 126].”
BackgroundArjan-Odedra, S., Swanson, C. M., Sherer, N. M., Wolinsky, S. M., & Malim, M. H. (2012) · Retrovirology · doi:10.1186/1742-4690-9-53 · Cited by 101
“Similarly, TRIM5 α [11], tetherin [12] and SAMHD1 [13,14] are restriction factors that can inhibit the replication of exogenous retroviruses at different steps in the retroviral life cycle [15].”
Phospho-dependent Regulation of SAMHD1 Oligomerisation Couples Catalysis and Restriction
Arnold, L. H., Groom, H. C. T., Kunzelmann, S., Schwefel, D., Caswell, S. J., Ordonez, P., Mann, M. C., Rueschenbaum, S., Goldstone, D. C., Pennell, S., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005194 · Cited by 117
Clerc, I., Moussa, D. A., Vahlas, Z., Tardito, S., Oburoglu, L., Hope, T. J., Sitbon, M., Dardalhon, V., Mongellaz, C., & Taylor, N. N. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0084-1 · Cited by 121
HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1
Harman, A. N., Nasr, N., Feetham, A., Galoyan, A., Alshehri, A. A., Rambukwelle, D., Botting, R. A., Hiener, B. M., Diefenbach, E., Diefenbach, R. J., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00889-15 · Cited by 110
“Our results may appear to be in conflict with those showing that reversal of inhibition of HIV reverse transcription by SAMHD1 in MDDCs by Vpx restores interferon production (51, 52), overwhelming any potential viral inhibitory mechanisms.”
ResultAllouch, A., David, A., Amie, S. M., Lahouassa, H., Chartier, L., Margottin-Goguet, F., Barré‐Sinoussi, F., Kim, B., Sáez‐Cirión, A., & Pancino, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306719110 · Cited by 106
“SIV and HIV-2 counteract SAMHD1 by the expression of Vpx, which targets SAMHD1 for proteosomal degradation, thus allowing these viruses to escape SAMHD1-mediated restriction in macrophages and dendritic cells (13, 14).”
BackgroundHost restriction factors in retroviral infection: promises in virus-host interaction
Zheng, Y., Jeang, K.-T., & Tokunaga, K. (2012) · Retrovirology · doi:10.1186/1742-4690-9-112 · Cited by 122
“The Vpx proteins were able to specifically trigger SAMHD1 degradation by the proteasomal pathway in these cells [315-317], and a similar observation was also made in resting CD4 T cells [301,302].”
BackgroundMethodResultInfluentialActin Dynamics Regulates Dendritic Cell-Mediated Transfer of HIV-1 to T Cells
Ménager, M. M., & Littman, D. R. (2016) · Cell · doi:10.1016/j.cell.2015.12.036 · Cited by 99
HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages
Lahouassa, H., Blondot, M.-L., Chauveau, L., Chougui, G., Morel, M., Leduc, M., Guillonneau, F., Ramirez, B. C., Schwartz, O., & Margottin-Goguet, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600485113 · Cited by 100
“Of note, we also validated our SILAC procedure with the observation that SAMHD1 levels were strongly decreased on delivery of HIV-2/SIVsmm Vpx protein as expected (57, 58).”
BackgroundMethodSelf-citationBobadilla, S., Sunseri, N., & Landau, N. R. (2013) · Gene Therapy · doi:10.1038/gt.2012.61 · Cited by 103
Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency
Friedli, M., Turelli, P., Kapopoulou, A., Rauwel, B., Castro-Díaz, N., Rowe, H. M., Ecco, G., Unzu, C., Planet, E., Lombardo, A., et al. (2014) · Genome Research · doi:10.1101/gr.172809.114 · Cited by 102
“, APOBEC3A and SAMHD1) (Bogerd et al. 2006; Hrecka et al. 2011; Laguette et al. 2011) were transiently induced during reprogramming (Supplemental Fig.”
BackgroundSwaminathan, G., Rossi, F., Sierra, L.-J., Gupta, A., Navas-Martín, S., & Martín-García, J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002937 · Cited by 103
Jiménez, V. C., Booiman, T., de Taeye, S. W., van Dort, K. A., Rits, M. A. N., Hamann, J., & Kootstra, N. A. (2012) · Scientific Reports · doi:10.1038/srep00763 · Cited by 111
Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction
Nguyen, H. C., Wang, W., & Xiong, Y. (2017) · Subcellular Biochemistry · doi:10.1007/978-3-319-46503-6_12 · Cited by 92
Pino, M., Erkizia, I., Benet, S., Erikson, E., Fernández‐Figueras, M. T., Guerrero, D., Dalmau, J., Ouchi, D., Rausell, A., Ciuffi, A., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0160-x · Cited by 106
“This is largely due to restriction by the cellular factor SAMHD1 in these cells [4,5].”
BackgroundType I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control
Soper, A., Kimura, I., Nagaoka, S., Konno, Y., Yamamoto, K., Koyanagi, Y., & Sato, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01823 · Cited by 112
“, macrophages and dendritic cells (DCs)] and CD4+ T cells (19).”
BackgroundThe Innate Immune Factor Apolipoprotein L1 Restricts HIV-1 Infection
Taylor, H. E., Khatua, A. K., & Popik, W. (2013) · Journal of Virology · doi:10.1128/jvi.02828-13 · Cited by 101
“Although expression of restriction factor Samhd1 in macrophages (60, 61) was not significantly afTaylor et al.”
BackgroundNguyen, P. V., Kafka, J. K., Ferreira, V. H., Roth, K., & Kaushic, C. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.41 · Cited by 120
Lv, L., Wang, Q., Xu, Y., Tsao, L.-C., Nakagawa, T., Guo, H., Su, L., & Xiong, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.05.007 · Cited by 100
“Vpx, a homolog of Vpr that is encoded by HIV-2 and most simian lentiviruses, also binds to VprBP and targets a host restriction factor, SAMHD1, for ubiquitylation by CRL4 and subsequent degradation by the proteasome (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundIzquierdo-Useros, N., Lorizate, M., Contreras, F.-X., Rodriguez-Plata, M. T., Glass, B., Erkizia, I., Prado, J. G., Casas, J., Fabriàs, G., Kräusslich, H.-G., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001315 · Cited by 93
“Hence, although myeloid cells are largely refractory to productive HIV-1 infection due to the presence of cellular restriction factors such as the recently identified SAMHD1 [19,20], the sialyllactose driven trans-infection process characterized here in mDCs seems to exploit a pre-existing cellulartrafficking machiner…”
BackgroundInfluentialIdentification of Cellular Proteins Interacting with the Retroviral Restriction Factor SAMHD1
Gelais, C. S., de Silva, S., Hach, J. C., White, T. E., Diaz‐Griffero, F., Yount, J. S., & Wu, L. J. (2014) · Journal of Virology · doi:10.1128/jvi.00155-14 · Cited by 112
“Interestingly, in DCs, expression of all interacting proteins was detectable, suggesting a potential equilibrium between the unphosphorylated and phosphorylated forms of SAMHD1, which is consistent with previous findings (22) and helps explain the very low levels of HIV-1 infection observed in DCs (5, 14).”
InfluentialHIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment
Carroll, A. S., & Brew, B. J. (2017) · F1000Research · doi:10.12688/f1000research.10651.1 · Cited by 108
Clustering and reverse transcription of HIV‐1 genomes in nuclear niches of macrophages
Rensen, E., Mueller, F., Scoca, V., Parmar, J. J., Souque, P., Zimmer, C., & Nunzio, F. D. (2020) · The EMBO Journal · doi:10.15252/embj.2020105247 · Cited by 104
Fregoso, O. I., Ahn, J., Wang, C., Mehrens, J., Skowronski, J., & Emerman, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003496 · Cited by 95
“resulting in productive infection [6,8,9].”
HIV-1 Nef: a multifaceted modulator of T cell receptor signaling
Abraham, L., & Fackler, O. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-39 · Cited by 111
“This Samhd1 dependent restriction might reflect the ability of this enzyme to reduce the pool of available dNTPs required for RT in resting but not activated T-lymphocytes, the latter of which display significantly higher dNTP levels.”
A G1‐like state allows HIV‐1 to bypass SAMHD1 restriction in macrophages
Mlčochová, P., Sutherland, K. A., Watters, S. A., Bertoli, C., de Bruin, R. A. M., Rehwinkel, J., Neil, S. J. D., Lenzi, G. M., Kim, B., Khwaja, A., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696025 · Cited by 106
“Some lentiviruses have evolved counter-measures against SAMHD1; for example, the HIV-2/SIVsm lineage encodes the Vpx protein that degrades SAMHD1 and allows infection of otherwise SAMHD1-positive target cells (Kaushik et al , 2009; Hrecka et al , 2011; Laguette et al , 2011).”
SAMHD1 Functions and Human Diseases
Coggins, S. A., Mahboubi, B., Schinazi, R. F., & Kim, B. (2020) · Viruses · doi:10.3390/v12040382 · Cited by 98
“HIV-2 and some SIVs circumvent host SAMHD1 restriction and rapidly replicate even in macrophages by inducing the proteasomal degradation of SAMHD1 through a viral accessory protein called viral protein X (Vpx) [81,82,100,101].”
BackgroundGreenwood, E. J., Matheson, N. J., Wals, K., van den Boomen, D. J., Antrobus, R., Williamson, J. C., & Lehner, P. J. (2016) · eLife · doi:10.7554/elife.18296 · Cited by 92
“HIV replication is tightly regulated by dNTP availability, and SAMHD1 (which tends to oppose the effects of RNR) is a well-described HIV restriction factor (Ayinde et al., 2012; Baldauf et al., 2012; Hrecka et al., 2011; Laguette et al., 2011; Lahouassa et al., 2012; Taylor et al., 2015).”
BackgroundGreenwood, E. J. D., Williamson, J. C., Sienkiewicz, A., Naamati, A., Matheson, N. J., & Lehner, P. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.025 · Cited by 91
“Two lentiviral lineages lack Vpx but use Vpr to degrade SAMHD1, whereas the HIV-1/SIVcpz lineage lacks SAMHD1 antagonism (Lim et al., 2012).”
BackgroundInfluentialThe biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus
van der Kuyl, A. C., & Berkhout, B. (2012) · Retrovirology · doi:10.1186/1742-4690-9-92 · Cited by 94
“SAMHD1 (sterile alpha factor and HD-domain 1) is another HIV-1 restriction factor that was recently identified [109,110].”
SAMHD1: At the Crossroads of Cell Proliferation, Immune Responses, and Virus Restriction
Ballana, E., & Esté, J. A. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.08.002 · Cited by 102
Ambrose, Z., Lee, K., Ndjomou, J., Xu, H., Oztop, I., Matous, J., Takemura, T., Unutmaz, D., Engelman, A., Hughes, S. H., et al. (2012) · Journal of Virology · doi:10.1128/jvi.05887-11 · Cited by 92
“Vpx has recently been shown to degrade the restriction factor SAMHD1 (11, 14).”
BackgroundStem memory T cells (TSCM)—their role in cancer and HIV immunotherapies
Flynn, J. K., & Gorry, P. R. (2014) · Clinical & Translational Immunology · doi:10.1038/cti.2014.16 · Cited by 82
Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells
Eichholz, K., Bru, T., Tran, T. T. P., Fernandes, P., Welles, H. C., Mennechet, F. J. D., Manel, N., Alves, P. M., Perreau, M., & Kremer, E. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005871 · Cited by 97
“To circumvent SAMHD1 (sterile alpha-motif domain and His-Asp domain-containing protein 1)-mediated restriction of lentivirus infection of human monocytes, we generated lentivirus particles containing Vpx [54,75].”
MethodInnate Antiviral Immune Signaling, Viral Evasion and Modulation by HIV-1
Rustagi, A., & Gale, M. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.12.003 · Cited by 107
“Of particular importance to macrophages and cDCs in HIV-1 infection was the discovery of the cellular SAMHD1 protein as a restriction factor for HIV-1 infection in these cells [188].”
BackgroundCyclinA2-Cyclin-dependent Kinase Regulates SAMHD1 Protein Phosphohydrolase Domain
Yan, J., Hao, C., DeLucia, M., Swanson, S. K., Florens, L. A., Washburn, M. P., Ahn, J., & Skowroński, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646588 · Cited by 94
Chemudupati, M., Kenney, A. D., Bonifati, S., Zani, A., McMichael, T. M., Wu, L. J., & Yount, J. S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.09.012 · Cited by 102
“A study performed in rhesus macaques infected with two SIV strains showed that Vpx is required in vivo for the establishment of productive infection in memory CD4+ T lymphocytes, confirming the role of SAMHD1 in retroviral replication and virus-induced immunodeficiency in vivo [123].”
BackgroundInfluentialIntracellular nucleotide levels and the control of retroviral infections
Amie, S. M., Noble, E., & Kim, B. (2012) · Virology · doi:10.1016/j.virol.2012.11.010 · Cited by 99
“clear example of a metabolic bottleneck that HIV has to counteract during viral infection (19, 23, 35, 36, 50).”
BackgroundZhou, D., Kang, K. H., & Spector, S. A. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis187 · Cited by 96
Sensor Sensibility—HIV-1 and the Innate Immune Response
Yin, X., Langer, S., Zhang, Z., Herbert, K. M., Yoh, S. M., König, R., & Chanda, S. K. (2020) · Cells · doi:10.3390/cells9010254 · Cited by 103
“Another study reported that SAMHD1 is able to directly interact with the inhibitor-κB kinase ε (IKKε) and IRF7 to suppress the innate immune response by reducing IKKε-mediated IRF7 phosphorylation [72,74].”
BackgroundInfluentialTherapies in Aicardi–Goutières syndrome
Crow, Y. J., Vanderver, A., Orcesi, S., Kuijpers, T. W., & Rice, G. I. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12115 · Cited by 88
Breugel, P. C. V., Robert, E. I., Mueller, H., Decorsière, A., Zoulim, F., Hantz, O., & Strubin, M. (2012) · Hepatology · doi:10.1002/hep.25928 · Cited by 91
“Another and perhaps more attractive possibility, which also relies on a E3 ligase substrate receptor function, is that HBx acts indirectly to counteract a cellular restriction factor by triggering its ubiquitin-mediated degradation, as shown recently for the Vpx protein of human immunodeficiency virus (HIV).(40,41) Th…”
Background
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.